WAYFIND-R is a registry that aims to capture high-quality real-world data linking next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a platform to support the design and conduct of clinical and epidemiological research; 2. To develop an evidence-generation platform to better understand health outcomes and cancer care processes; and 3. To characterize the treatments and clinical course of solid tumor cancers in patients who have undergone NGS testing.
Study Type
OBSERVATIONAL
Enrollment
15,000
Instituto Alexander Fleming
Buenos Aires, Argentina
RECRUITINGCEMIC
Buenos Aires, Argentina
RECRUITINGLkh-Univ. Klinikum Graz
Graz, Austria
RECRUITINGHospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
RECRUITINGInstituto do Cancer do Estado de Sao Paulo - ICESP
São Paulo, São Paulo, Brazil
RECRUITINGHospital Alemao Oswaldo Cruz
São Paulo, São Paulo, Brazil
RECRUITINGD'or Instituto de Pesquisa e Educação
Rio de Janeiro, Brazil
RECRUITINGBeneficencia Portuguesa de Sao Paulo
São Paulo, Brazil
RECRUITINGAlberta Health Services
Calgary, Alberta, Canada
RECRUITINGThe Ottawa Hospital - General Campus
Ottawa, Ontario, Canada
RECRUITING...and 127 more locations
Overall Survival
Time frame: From date of registry entry until death, for up to 5 years
Reference Study ID # MX39897 https://forpatients.roche.com/
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.